Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, Tyler J., Wei, Shuang, Dong, Haidong, Alvarez, Xavier, Cheng, Pui, Mottram, Peter, Krzysiek, Roman, Knutson, Keith L. +14 more·2003·Nature Medicine

DOI 10.1038/nm863

Cited by (1,000)

Items 301–400 of 1,000

Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, Ammar Khaled Daoud · 2020 · Open Biology
Direct and indirect regulation of the tumor immune microenvironment by VEGF
Yuqing Zhang, Rolf A. Brekken · 2022 · Journal of Leukocyte Biology
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
Sandra D. Bohling, Kimberly H. Allison · 2008 · Modern Pathology
Tumor associated regulatory dendritic cells
Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin, Michael R. Shurin · 2012 · Seminars in Cancer Biology
Checkpoint inhibitors in hematological malignancies
Chi Young Ok, Ken H. Young · 2017 · Journal of Hematology & Oncology
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, Danielle J. Smith, Mechthild Krause, Esther G.C. Troost, Catharine West, Peter Hoskin, Ananya Choudhury · 2024 · Frontiers in Oncology
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
Wenjing Qian, Mingfang Zhao, Ruoyu Wang, Heming Li · 2021 · Journal of Hematology & Oncology
Immunotherapy comes of age: Immune aging & checkpoint inhibitors
Elias, Rawad, Karantanos, Theodoros, Sira, Elizabeth, Hartshorn, Kevan L. · 2017 · Journal of Geriatric Oncology
In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer–Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
Uciane K. Scarlett, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth, Diana G. Martinez, Xavier A. Engle, Andrew T. Gewirtz, Cory L. Ahonen, Jose Ramon Conejo-Garcia · 2009 · Cancer Research
Clinical Significance of B7‐H1 and B7‐1 Expressions in Pancreatic Carcinoma
Liancai Wang, Qingyong Ma, Xiangli Chen, Kun Guo, Junhui Li, Min Zhang · 2010 · World Journal of Surgery
CTLA ‐4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
Luis H. Camacho · 2015 · Cancer Medicine
Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
Taku Fujimura, Sabine Ring, Viktor Umansky, Karsten Mahnke, Alexander Enk · 2011 · Journal of Investigative Dermatology
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Chiara Porta, Francesca Maria Consonni, Sara Morlacchi, Sabina Sangaletti, Augusto Bleve, Maria Grazia Totaro, Paola Larghi, Monica Rimoldi, Claudio Tripodo, Laura Strauss et al. · 2020 · Cancer Research
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander M.M. Eggermont, Isabelle Cremer, Wolf H. Fridman, Jitka Palich Fucikova, Jérôme Galon, Aurélien Marabelle et al. · 2015 · OncoImmunology
Immunity and Immune Suppression in Human Ovarian Cancer
Claudia C. Preston, Ellen L. Goode, Lynn C. Hartmann, Kimberly R. Kalli, Keith L. Knutson · 2011 · Immunotherapy
Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
Qin Fan, Zhipeng Chen, Chao Wang, Zhuang Liu · 2018 · Advanced Functional Materials
Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
Rachel M. Gibbons Johnson, Haidong Dong · 2017 · Frontiers in Immunology
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
Maria Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro, Patricia V. Elizalde, Roxana Schillaci · 2021 · Cancers
Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah Noelle Bell, Weiping Zou · 2024 · Annual Review of Immunology
Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression
Regina Lin, Ling Chen, Gang Chen, Chunyan Hu, Shan Jiang, Jose Sevilla, Ying Wan, John Howard Sampson, Bo Zhu, Qi-Jing Li · 2014 · Journal of Clinical Investigation
Blocking Programmed Death-1 Ligand-PD-1 Interactions by Local Gene Therapy Results in Enhancement of Antitumor Effect of Secondary Lymphoid Tissue Chemokine
Yufei He, Guimei Zhang, Xiaohong Wang, Hui Zhang, Ye Yuan, Dong Li, Zuo‐Hua Feng · 2004 · The Journal of Immunology
Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
Yuan Zhuang, Liu‐sheng Peng, Yongliang Zhao, Yun Shi, Xuhu Mao, Gang Guo, Weisan Chen, Xiaofei Liu, Jinyu Zhang, Tao Liu et al. · 2012 · Cancer Immunology Immunotherapy
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer
Christian J. Maine, Nor Haslinda Abd Aziz, Jayanta Chatterjee, Claudia Hayford, Nancy Brewig, Lynsey May Whilding, Andrew J.T. George, Sadaf Ghaem‐Maghami · 2013 · Cancer Immunology Immunotherapy
B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B
Liangen Chen, Zheng Zhang, Weiwei Chen, Zhidong Zhang, Yonggang Li, Ming Shi, Ji‐Yuan Zhang, Lieping Chen, Shengdian Wang, Fu‐Sheng Wang · 2007 · The Journal of Immunology
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
Fang Wei, Dan Wang, Junyuan Wei, Niwen Tang, Le Min Tang, Fang Xiong, Can Jie Guo, Ming Zhou, Xiaoling Li, Guiyuan Li et al. · 2020 · Cellular and Molecular Life Sciences
Optimizing dendritic cell?based anticancer immunotherapy: maturation state does have clinical impact
Dorian McIlroy, Marc Grégoire · 2003 · Cancer Immunology Immunotherapy
Tumor microenvironment (TME)-driven immune suppression in B cell malignancy
Nicole S. Nicholas, Benedetta Apollonio, Alan G. Ramsay · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy
Xilong Wu, Yundi Wu, Hongbo Ye, Shuangjiang Yu, Chaoliang He, Xuesi Chen · 2017 · Journal of Controlled Release
Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids
Tokunaga, Akihiro, Sugiyama, Daisuke, Maeda, Yuka, Warner, Allison Betof, Panageas, Katherine S., Ito, Sachiko, Togashi, Yosuke, Sakai, Chika, Wolchok, Jedd D., Nishikawa, Hiroyoshi · 2019 · Journal of Experimental Medicine
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy.
Dallas B. Flies, Britt J. Sandler, Mario Sznol, Lieping Chen · 2011 · Europe PMC (PubMed Central)
Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
Omid Hamid, Richard D. Carvajal · 2013 · Expert Opinion on Biological Therapy
Hypoxia-inducible factors in cancer stem cells and inflammation
Gong Peng, Yang Liu · 2015 · Trends in Pharmacological Sciences
Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells
Laura M. McLane, Shin Foong Ngiow, Zeyu Chen, John Attanasio, Sasikanth Manne, Gordon T. Ruthel, Jennifer E. Wu, Ryan P. Staupe, Wei Xu, Ravi K. Amaravadi et al. · 2021 · Cell Reports
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Alessandro Delli Poggi, Alessandra Musso, Irene Dapino, Maria Raffaella Zocchi · 2014 · Immunology Letters
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
Harshita B. Gupta, Curtis A. Clark, Bin Yuan, Gangadhara R. Sareddy, Srilakshmi Pandeswara, Alvaro Souto Padron, Vincent J. Hurez, Jose Ramon Conejo-Garcia, Ratna K. Vadlamudi, Rong Li et al. · 2016 · Signal Transduction and Targeted Therapy
The expanding role of immunotherapy
Juan Martín-Liberal, María Ochoa de Olza, Cinta Hierro, Alena Gros, Jordi Ahnert Rodon, Josep M. Tabernero · 2017 · Cancer Treatment Reviews
Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition
Florine A. Eggink, Inge C. van Gool, Alexandra F. Leary, Pamela M. Pollock, Emma Jayne Crosbie, Linda Mileshkin, Ekaterina S. Jordanova, Julien Adam, Luke Freeman-Mills, David N. Church et al. · 2016 · OncoImmunology
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial
Rodney Paul Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve, Jonathan Oh, Devansu S. Tewari, Peter C Morris, Erin Stevens, Justin N. Bottsford-Miller et al. · 2020 · The Lancet Oncology
Human CD4+CD25high Regulatory T Cells Modulate Myeloid but Not Plasmacytoid Dendritic Cells Activation
Roch Houot, Ivan Perrot, Eric Garcia, Isabelle Durand, Serge Lebecque · 2006 · The Journal of Immunology
Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance
Yiting Geng, Hui Wang, LU Chang-qing, Qing Li, Bin Xu, Jingting Jiang, Changping Wu · 2014 · International Journal of Clinical Oncology
TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
Vesna Pulko, Xin Liu, Christopher J. Krco, Kimberley J Harris, Xavier Frigola, Eugene D. Kwon, Haidong Dong · 2009 · The Journal of Immunology
Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
Mannon Geindreau, François Ghiringhelli, Mélanie Bruchard · 2021 · International Journal of Molecular Sciences
TKIs in combination with immunotherapy for hepatocellular carcinoma
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito · 2023 · Expert Review of Anticancer Therapy
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
Lei Geng, Dongsheng Huang, Junwei Liu, Yigang Qian, Junfang Deng, Donglin Li, Zhenhua Hu, Jian Zhang, Guoping Jiang, Shusen Zheng · 2008 · Journal of Cancer Research and Clinical Oncology
A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
Yohei Takeda, Keisuke Kataoka, Junya Yamagishi, Seishi Ogawa, Tsukasa Seya, Misako Matsumoto · 2017 · Cell Reports
Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses
Shengdian Wang, Lieping Chen · 2004 · Microbes and Infection
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
Francesco Torino, Agnese Barnabei, Rosa Maria Paragliola, Paolo Marchetti, Roberto Salvatori, Salvatore Maria Corsello · 2013 · European Journal of Endocrinology
Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment
Jason R. Baird, Barbara A. Fox, Kiah L. Sanders, Patrick Hall Lizotte, Juan R. Cubillos‐Ruiz, Uciane K. Scarlett, Melanie R. Rutkowski, Jose Ramon Conejo-Garcia, Steven Fiering, David J. Bzik · 2013 · Cancer Research
Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice
Elena Burova, Aynur Hermann, Janelle C. Waite, Terra B. Potocky, Venus Ka-Man Lai, Seongwon Hong, Matt Liu, Omaira Allbritton, Amy Woodruff, Qi Wu et al. · 2017 · Molecular Cancer Therapeutics
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
Kevin Wang, Paulina Coutifaris, David Brocks, Guanning Wang, Tarek Azar, Sabrina M. Solis, Ajeya Nandi, Shaneaka Anderson, Nicholas A. Han, Sasikanth Manne et al. · 2024 · Cancer Cell
High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
Anne Marijne Heeren, Bas D. Koster, Sanne Samuels, Debbie M. Ferns, Dafni Chondronasiou, Gemma G. Kenter, Ekaterina S. Jordanova, Tanja D. de Gruijl · 2014 · Cancer Immunology Research
Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
Robert D. Carlson, John C. Flickinger, Adam Eugene Snook · 2020 · Toxins
The complementarity of DDR, nucleic acids and anti-tumour immunity
Anand V. R. Kornepati, Cody M. Rogers, Patrick Sung, Tyler Jay Curiel · 2023 · Nature
Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy
Weiping Zou, Douglas R. Green · 2023 · Cell Metabolism
Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy
Junya Zhang, Yuxuan Hu, Xidan Wen, Zeyue Yang, Ziyi Wang, Zhiyuan Feng, Bai He, Qi Xue, Yinxing Miao, Tian Tian et al. · 2025 · Nature Nanotechnology
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, Xiang‐Ming Lao, Weiming Lin, Dong‐Ping Chen, Ming Mu, Chun-Xiang Huang, Zhengyu Liu, Bo Li et al. · 2019 · Journal of Clinical Investigation
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Timothy N. J. Bullock · 2021 · Cellular and Molecular Immunology
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Katrin Pansy, Barbara Uhl, Jelena Krstić, Marta Szmyra, Karoline Fechter, Ana Santiso, Lea Thüminger, Hildegard Greinix, Julia Kargl, Katharina Theresa Prochazka et al. · 2021 · International Journal of Molecular Sciences
Metabolism Is Central to Tolerogenic Dendritic Cell Function
Wen Jing Sim, Patricia Jennifer Ahl, John Edward Connolly · 2016 · Mediators of Inflammation
Peptides Identified through Phage Display Direct Immunogenic Antigen to Dendritic Cells
Tyler Jay Curiel, Cindy Bohan Morris, Michael J. Brumlik, Samuel J. Landry, Kristiaan Finstad, Anne Nelson, Virendra Joshi, Christopher Hawkins, Xavier Alarez, Andrew A. Lackner et al. · 2004 · The Journal of Immunology
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
Kenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, Tricia Bal, Ezra E.W. Cohen, Kevin Joseph Harrington, Denis Soulières, Christophe Le Tourneau, Lisa Francesca Licitra, Barbara Ann Burtness et al. · 2020 · Modern Pathology
The nature of activatory and tolerogenic dendritic cell-derived signal II
Ghaith Bakdash, Simone P. Sittig, Tjeerd van Dijk, Carl Gustav Figdor, I. Jolanda M. de Vries · 2013 · Frontiers in Immunology
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
Jorrit De Waele, Tias Verhezen, Sanne van der Heijden, Zwi Nisan Berneman, Marc Peeters, Filip Lardon, An Wouters, Evelien Smits · 2021 · Journal of Experimental & Clinical Cancer Research
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma
Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, Elham Karimi, Lotte W.H.G. van Mil, Awa A. Gassama, Beatriz Gomez Solsona, Marnix H. P. de Groot, Dieta Brandsma, Daniela F. Quail et al. · 2023 · Nature Cancer
Control of Established Melanoma by CD27 Stimulation Is Associated With Enhanced Effector Function and Persistence, and Reduced PD-1 Expression of Tumor Infiltrating CD8+ T Cells
Drew J. Roberts, Nathan A. Franklin, Lara M. Kingeter, Hideo Yagita∥, Alison L. Tutt, Martin J. Glennie, Timothy N. J. Bullock · 2010 · Journal of Immunotherapy
Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms
Gregory A. Lizee, Laszlo George Radvanyi, Willem W. Overwijk, Patrick Hwu · 2006 · Clinical Cancer Research
Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
Vincent J. Hurez, Benjamin J. Daniel, Lishi Sun, AiJie Liu, Sara M. Ludwig, Mark J. Kious, Suzanne R. Thibodeaux, Srilakshmi Pandeswara, Kruthi Murthy, Carolina Becker Livi et al. · 2012 · Cancer Research
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target
Il‐Kyoo Park, Anjali Mishra, Jason Claud Chandler, Susan P. Whitman, Guido Marcucci, Michael A. Caligiuri · 2013 · Blood
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
Jun Wang, Ruirong Yuan, Wenru Song, Jingwei Sun, Delong Liu, Zihai Li · 2017 · Journal of Hematology & Oncology
Spatial and phenotypic immune profiling of metastatic colon cancer
Jenny Lazarus, Tomasz Maj, Jesse Joshua Smith, Mirna Perusina Lanfranca, Arvind U.K. Rao, Michael Ian D'Angelica, Lawrence Delrosario, Alexander A. Girgis, Casey P. Schukow, Jinru Shia et al. · 2018 · JCI Insight
Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
Mark J. Dobrzanski · 2013 · Frontiers in Oncology
B7-homolog 1 expression by human glioma: a new mechanism of immune evasion
Rick Wilmotte, Karim Burkhardt, Vincent Kindler, Marie‐Claude Belkouch, G raldine Dussex, Nicolas de Tribolet, Paul R. Walker, Pierre‐Yves Dietrich · 2005 · Neuroreport
PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis
Hanlu Ding, Xiongfei Wu, Wenda Gao · 2005 · Clinical Immunology
PD-1 regulates extrathymic regulatory T-cell differentiation
Chen, Xiufen, Fosco, Dominick, Kline, Douglas E., Meng, Liping, Nishi, Saki, Savage, Peter A., Kline, Justin · 2014 · European Journal of Immunology
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
Paola Ciciola, Priscilla Cascetta, Cataldo Bianco, Luigi Formisano, Roberto Bianco · 2020 · Journal of Clinical Medicine
Tumor-induced modulation of dendritic cell function
Eva Gottfried, Marina P Kreutz, Andréas Mackensen · 2007 · Cytokine & Growth Factor Reviews
Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma
Fumihiko Tsushima, Kae Tanaka, Noriko Otsuki, Pornpan Youngnak‐Piboonratanakit, Hideyuki Iwai, Ken Omura, Miyuki Azuma · 2005 · Oral Oncology
Cardiorenal complications of immune checkpoint inhibitors
Krishna Sury, Mark Anthony Perazella, Anushree C. Shirali · 2018 · Nature Reviews Nephrology
Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Jens Martin Werner, Svetlana Karakhanova · 2018 · Frontiers in Immunology
The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials
Anwaar Saeed, Robin Park, Weijing Sun · 2021 · Journal of Hematology & Oncology
Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan · 2023 · Frontiers in Immunology
Generation of myeloid-derived suppressor cells using prostaglandin E2
Nataša Obermajer, Paweł Kaliński · 2012 · Transplantation Research
Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors
Toshihiro Nagato, Young-Ran Lee, Yasuaki Harabuchi, Esteban Celis · 2014 · Clinical Cancer Research
Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
Sadique Akhtar Javed, Asim Najmi, Waquar Ahsan, Khalid A. Zoghebi · 2024 · Frontiers in Immunology
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
Peter S. Goedegebuure, Jonathan B. Mitchem, Matthew R. Porembka, Marcus Chuan Beng Tan, Brian A. Belt, Andrea Wang‐Gillam, William E. Gillanders, William G. Hawkins, David C. Linehan · 2011 · Current Cancer Drug Targets
Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment
Amorette E. Barber, Agnieszka Rynda, Charles L. Sentman · 2009 · The Journal of Immunology
B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer
Yu Liu, Bin Zeng, Zhuohan Zhang, Yuan Clare Zhang, Rongcun Yang · 2008 · Clinical Immunology
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
Alexandra Cioroianu, Patricia- Irina Stinga, Liana Sticlaru, Mirela Daniela Cioplea, Luciana Nichita, Cristiana Gabriela Popp, Florica Stăniceanu · 2019 · Analytical Cellular Pathology
The immunoinhibitory B7-H1 molecule as a potential target in cancer
Said Dermime, Sehar Afreen · 2014 · Hematology/Oncology and Stem Cell Therapy
TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells
Yigang Qian, Junfang Deng, Lei Geng, Haiyang Xie, Guoping Jiang, Lin Zhou, Yan Wang, Shenyong Yin, Xiaowen Feng, Junwei Liu et al. · 2008 · Cancer Investigation
Immunotherapy of malignant brain tumors
Duane A. Mitchell, Peter Edward Fecci, John Howard Sampson · 2008 · Immunological Reviews
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200
Amara C. Siva, H. Xin, Fenghua Qin, Daniela I. Oltean, Katherine S. Bowdish, Anke Kretz-Rommel · 2007 · Cancer Immunology Immunotherapy
Graft‐infiltrating PD‐L1hi cross‐dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance
Yoshihiro Ono, Angélica Pérez-Gutiérrez, Toshimasa Nakao, Helong Dai, Geoffrey Camirand, Osamu Yoshida, Shinichiro Yokota, Donna Beer Stolz, Mark A. Ross, Adrián E. Morelli et al. · 2017 · Hepatology
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials
Alessandro Di Federico, Alessandro Rizzo, Riccardo Carloni, Andrea De Giglio, Riccardo Bruno, Dalia Ricci, Giovanni Brandi · 2021 · Expert Opinion on Investigational Drugs
T-cell regulation in rheumatoid arthritis
Jörg J. Goronzy, Cornelia M. Weyand · 2004 · Current Opinion in Rheumatology
The regulation of lymphocyte activation by inhibitory receptors
Paul J. Leibson · 2004 · Current Opinion in Immunology
Targeting Costimulatory Molecules to Improve Antitumor Immunity
Daria Capece, Daniela Verzella, Mariafausta Fischietti, Francesca Zazzeroni, Edoardo Alesse · 2012 · BioMed Research International
Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
Song Xue, Man Hu, Peifeng Li, Ji Ma, Li Xie, Feifei Teng, Yufang Zhu, Bingjie Fan, Dianbin Mu, Jinming Yu · 2017 · Oncotarget
Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
Bogang Wu, Xiujie Sun, Harshita B. Gupta, Bin Yuan, Jingwei Li, Fei Ge, Huai-Chin Chiang, Xiaowen Zhang, Chi Zhang, Deyi Zhang et al. · 2018 · OncoImmunology
Icaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice
Haibang Hao, Qi Zhang, Hai Zhu, Yuxiang Wen, Ding Qiu, Jian Xiong, Xiaolan Fu, Yuzhang Wu, Kun Meng, Jian Li · 2019 · European Journal of Immunology